多发性-话题@MedSci

#多发性#

905篇内容 | 2947人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890075, encodeId=dc6018900e5cc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=美国临床医生最喜欢哪款多发性硬化症药物？诺华、默克还是Biogen的？, objectType=article, longId=183458, objectId=aa7d1834581c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa7d1834581c, replyNumber=0, likeNumber=60, createdTime=2020-05-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa7d1834581c, moduleTitle=美国临床医生最喜欢哪款多发性硬化症药物？诺华、默克还是Biogen的？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa7d1834581c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890047, encodeId=9210189004ece, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA Neurol：血清神经丝轻链(sNFL)用于多发性硬化病情评估, objectType=article, longId=177647, objectId=0b601e7647ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b601e7647ac, replyNumber=0, likeNumber=67, createdTime=2020-04-01, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b601e7647ac, moduleTitle=JAMA Neurol：血清神经丝轻链(sNFL)用于多发性硬化病情评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b601e7647ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890043, encodeId=ccc1189004391, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞, objectType=article, longId=176318, objectId=a36e1e6318f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a36e1e6318f6, replyNumber=0, likeNumber=83, createdTime=2020-03-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a36e1e6318f6, moduleTitle=J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a36e1e6318f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889994, encodeId=9a691889994d9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：伊沙妥昔单抗联合泊马度胺/地塞米松可安全有效的治疗复发性/难治性多发性骨髓瘤, objectType=article, longId=162664, objectId=aad916266487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aad916266487, replyNumber=0, likeNumber=72, createdTime=2019-03-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aad916266487, moduleTitle=Blood：伊沙妥昔单抗联合泊马度胺/地塞米松可安全有效的治疗复发性/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aad916266487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890040, encodeId=bb53189004046, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Nature：研究发现多发性硬化相关细胞改变, objectType=article, longId=175955, objectId=e3731e5955de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3731e5955de, replyNumber=0, likeNumber=69, createdTime=2020-01-14, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3731e5955de, moduleTitle=Nature：研究发现多发性硬化相关细胞改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3731e5955de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890001, encodeId=bf83189000128, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=PNAS：开发多发性骨髓瘤治疗新策略, objectType=article, longId=164534, objectId=cc5516453468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc5516453468, replyNumber=0, likeNumber=65, createdTime=2020-01-05, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc5516453468, moduleTitle=PNAS：开发多发性骨髓瘤治疗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc5516453468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890006, encodeId=afed18900069d, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=AAN：II期临床试验证实口服Bruton酪氨酸激酶（BTK）抑制剂治疗多发性硬化症的有效性, objectType=article, longId=165920, objectId=671e16592080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=671e16592080, replyNumber=0, likeNumber=66, createdTime=2020-03-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=671e16592080, moduleTitle=AAN：II期临床试验证实口服Bruton酪氨酸激酶（BTK）抑制剂治疗多发性硬化症的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=671e16592080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890021, encodeId=922b189002109, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=第24届EHA大会：Melflufen治疗复发难治多发性骨髓瘤的全新阳性数据, objectType=article, longId=168709, objectId=d348168e091c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d348168e091c, replyNumber=0, likeNumber=110, createdTime=2020-05-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d348168e091c, moduleTitle=第24届EHA大会：Melflufen治疗复发难治多发性骨髓瘤的全新阳性数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d348168e091c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889980, encodeId=91b91889980a9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=【盘点】近期多发性骨髓瘤重要研究进展汇总, objectType=article, longId=159875, objectId=95ef1598e5cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95ef1598e5cf, replyNumber=0, likeNumber=54, createdTime=2019-05-15, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95ef1598e5cf, moduleTitle=【盘点】近期多发性骨髓瘤重要研究进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95ef1598e5cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890024, encodeId=31041890024ee, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA Neurol：早发性多发性硬化患者认知下降速度增加, objectType=article, longId=170098, objectId=bc731e0098ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc731e0098ac, replyNumber=0, likeNumber=67, createdTime=2019-11-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc731e0098ac, moduleTitle=JAMA Neurol：早发性多发性硬化患者认知下降速度增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc731e0098ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889988, encodeId=f91c1889988c9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=超声诊断胎儿心脏多发性肿物一例, objectType=article, longId=160960, objectId=962e16096025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=962e16096025, replyNumber=0, likeNumber=66, createdTime=2019-11-22, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=962e16096025, moduleTitle=超声诊断胎儿心脏多发性肿物一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=962e16096025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890071, encodeId=b68718900e162, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019 意大利共识：多发性硬化痉挛的治疗, objectType=article, longId=182403, objectId=ce8e182403a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce8e182403a8, replyNumber=0, likeNumber=53, createdTime=2020-01-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce8e182403a8, moduleTitle=2019 意大利共识：多发性硬化痉挛的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce8e182403a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890058, encodeId=96e81890058dc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Ann Neurol：端粒长度与多发性硬化症的残疾进展有关, objectType=article, longId=179307, objectId=f9301e930794, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9301e930794, replyNumber=0, likeNumber=92, createdTime=2020-07-22, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9301e930794, moduleTitle=Ann Neurol：端粒长度与多发性硬化症的残疾进展有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9301e930794)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890029, encodeId=bc4918900293d, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA批准Karyopharm的核输出抑制剂Xpovio用于治疗复发或难治的多发性骨髓瘤, objectType=article, longId=174802, objectId=d82e1e480215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82e1e480215, replyNumber=0, likeNumber=96, createdTime=2020-01-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82e1e480215, moduleTitle=FDA批准Karyopharm的核输出抑制剂Xpovio用于治疗复发或难治的多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82e1e480215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890002, encodeId=4bdf189000281, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2018 JSH实践指南：血液恶性肿瘤—骨髓瘤：多发性骨髓瘤相关疾病, objectType=article, longId=164962, objectId=e9181649624f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9181649624f, replyNumber=0, likeNumber=20, createdTime=2019-08-28, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9181649624f, moduleTitle=2018 JSH实践指南：血液恶性肿瘤—骨髓瘤：多发性骨髓瘤相关疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9181649624f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890038, encodeId=5c6b18900383a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA Neurol：肥胖、儿童多发性硬化风险与一线疗法响应, objectType=article, longId=175688, objectId=8e6c1e568867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e6c1e568867, replyNumber=0, likeNumber=68, createdTime=2019-11-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e6c1e568867, moduleTitle=JAMA Neurol：肥胖、儿童多发性硬化风险与一线疗法响应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e6c1e568867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890004, encodeId=913f1890004f7, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=硼替佐米治疗多发性骨髓瘤骨病1例, objectType=article, longId=165810, objectId=cfdc165810c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfdc165810c7, replyNumber=0, likeNumber=66, createdTime=2019-10-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfdc165810c7, moduleTitle=硼替佐米治疗多发性骨髓瘤骨病1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfdc165810c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890055, encodeId=9c10189005574, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：硼替佐米、来那度胺和地塞米松诱导方案用于多发性骨髓瘤患者骨髓移植前的疗效和安全性, objectType=article, longId=179006, objectId=faa21e9006ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faa21e9006ac, replyNumber=0, likeNumber=66, createdTime=2019-10-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faa21e9006ac, moduleTitle=Blood：硼替佐米、来那度胺和地塞米松诱导方案用于多发性骨髓瘤患者骨髓移植前的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faa21e9006ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890028, encodeId=48451890028ee, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=美国FDA批准daratumumab联合来那度胺和地塞米松治疗初治多发性骨髓瘤, objectType=article, longId=174421, objectId=3d441e442153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d441e442153, replyNumber=0, likeNumber=66, createdTime=2019-12-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d441e442153, moduleTitle=美国FDA批准daratumumab联合来那度胺和地塞米松治疗初治多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d441e442153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890020, encodeId=fc25189002013, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=从新诊断到复发难治，来那度胺为基础的方案在多发性骨髓瘤治疗中角色凸显, objectType=article, longId=168452, objectId=0fcc1684525d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fcc1684525d, replyNumber=0, likeNumber=63, createdTime=2019-07-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fcc1684525d, moduleTitle=从新诊断到复发难治，来那度胺为基础的方案在多发性骨髓瘤治疗中角色凸显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fcc1684525d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

美国临床医生最喜欢哪款多发性硬化症药物？诺华、默克还是Biogen的？

2020-05-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JAMA Neurol：血清神经丝轻链(sNFL)用于多发性硬化病情评估

2020-04-01

jml2009 (审核中...)

前往app查看评论内容

#多发性#

J Immunol：IL-11在多发性硬化症和自身免疫性脑脊髓炎中诱导脑炎性Th17细胞

2020-03-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：伊沙妥昔单抗联合泊马度胺/地塞米松可安全有效的治疗复发性/难治性多发性骨髓瘤

2019-03-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Nature：研究发现多发性硬化相关细胞改变

2020-01-14

jml2009 (审核中...)

前往app查看评论内容

#多发性#

PNAS：开发多发性骨髓瘤治疗新策略

2020-01-05

jml2009 (审核中...)

前往app查看评论内容

#多发性#

AAN：II期临床试验证实口服Bruton酪氨酸激酶（BTK）抑制剂治疗多发性硬化症的有效性

2020-03-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

第24届EHA大会：Melflufen治疗复发难治多发性骨髓瘤的全新阳性数据

2020-05-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

【盘点】近期多发性骨髓瘤重要研究进展汇总

2019-05-15

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JAMA Neurol：早发性多发性硬化患者认知下降速度增加

2019-11-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

超声诊断胎儿心脏多发性肿物一例

2019-11-22

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019 意大利共识：多发性硬化痉挛的治疗

2020-01-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Ann Neurol：端粒长度与多发性硬化症的残疾进展有关

2020-07-22

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA批准Karyopharm的核输出抑制剂Xpovio用于治疗复发或难治的多发性骨髓瘤

2020-01-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2018 JSH实践指南：血液恶性肿瘤—骨髓瘤：多发性骨髓瘤相关疾病

2019-08-28

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JAMA Neurol：肥胖、儿童多发性硬化风险与一线疗法响应

2019-11-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

硼替佐米治疗多发性骨髓瘤骨病1例

2019-10-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：硼替佐米、来那度胺和地塞米松诱导方案用于多发性骨髓瘤患者骨髓移植前的疗效和安全性

2019-10-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

美国FDA批准daratumumab联合来那度胺和地塞米松治疗初治多发性骨髓瘤

2019-12-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

从新诊断到复发难治，来那度胺为基础的方案在多发性骨髓瘤治疗中角色凸显

2019-07-12

科室
- - 订阅+
  - 更多科室
工具
服务